2Xideas AG Sells 16,481 Shares of Align Technology, Inc.

The firm lowered its stake in the medical equipment provider by 50.8% in the 3rd quarter.

Mar. 14, 2026 at 7:04am

Got story updates? Submit your updates here. ›

2Xideas AG, an investment firm, lowered its stake in Align Technology, Inc. (NASDAQ:ALGN) by 50.8% in the 3rd quarter, according to the company's recent SEC filing. The firm now owns 15,948 shares of the medical equipment provider's stock, down from 32,429 shares previously.

Why it matters

Align Technology is a leading provider of digital orthodontic solutions, including its flagship Invisalign system. The company's stock performance and ownership changes by major investors can provide insights into market sentiment and the overall health of the business.

The details

In its SEC filing, 2Xideas AG reported selling 16,481 shares of Align Technology during the 3rd quarter. The firm's holdings in Align Technology are now valued at $1,997,000, down from $4,068,000 at the end of the previous quarter.

  • 2Xideas AG lowered its stake in Align Technology in the 3rd quarter of 2026.

The players

2Xideas AG

An investment firm that previously held a significant stake in Align Technology, Inc.

Align Technology, Inc.

A medical equipment provider and the maker of the Invisalign clear aligner system.

Got photos? Submit your photos here. ›

The takeaway

The reduction in 2Xideas AG's stake in Align Technology suggests a shift in the investment firm's outlook on the company, which could be influenced by factors such as market conditions, competition, or the firm's own investment strategy. However, Align Technology remains a major player in the digital orthodontics market, and its long-term performance will depend on its ability to maintain its technological edge and market share.